open access

Vol 15, No 2 (2012)
Reviews
Published online: 2012-08-28
Submitted: 2012-08-31
Accepted: 2012-08-31
Get Citation

Iodine-131 for therapy of thyroid diseases. Physical and biological basis

Anna Wyszomirska
Nucl. Med. Rev 2012;15(2):120-123.

open access

Vol 15, No 2 (2012)
Reviews
Published online: 2012-08-28
Submitted: 2012-08-31
Accepted: 2012-08-31

Abstract

Iodine-131 is successfully used in the treatment of hyperthyroidism
and differentiated thyroid cancer. Thyroid is the critical
organ for iodine. Iodine is taken up by the thyroid follicular cells.
Radioactive isotope iodine-131 simultaneously emits two types
of radiation: radiation beta minus (b-) used for the treatment and
gamma (g) used for diagnosis. Due to the penetration of beta
particles in tissue, damaging effect of b-radiation is restricted to
thyroid cells. In this article, characteristic of iodine-131, mechanism
of action and mechanism of tissue damage is presented.
HIGH energy g-ray emission, contributes to the dose of both: patient’s
body and the personnel. In accordance with the principles
of radiation protection, reducing exposure to ionizing radiation
should be achieved by: use of proper shieldings, organization
of work, appropriate distance from the radiation source and
reducing the time of exposure. Treatment with I-131, depending
on medical indications, may be carried out on stationary
or outpatient basis. All activities conducted in the exposure to
radiation must comply with the principles of radiation protection,
in accordance with the applicable regulations, that are also
presented in this article.

Abstract

Iodine-131 is successfully used in the treatment of hyperthyroidism
and differentiated thyroid cancer. Thyroid is the critical
organ for iodine. Iodine is taken up by the thyroid follicular cells.
Radioactive isotope iodine-131 simultaneously emits two types
of radiation: radiation beta minus (b-) used for the treatment and
gamma (g) used for diagnosis. Due to the penetration of beta
particles in tissue, damaging effect of b-radiation is restricted to
thyroid cells. In this article, characteristic of iodine-131, mechanism
of action and mechanism of tissue damage is presented.
HIGH energy g-ray emission, contributes to the dose of both: patient’s
body and the personnel. In accordance with the principles
of radiation protection, reducing exposure to ionizing radiation
should be achieved by: use of proper shieldings, organization
of work, appropriate distance from the radiation source and
reducing the time of exposure. Treatment with I-131, depending
on medical indications, may be carried out on stationary
or outpatient basis. All activities conducted in the exposure to
radiation must comply with the principles of radiation protection,
in accordance with the applicable regulations, that are also
presented in this article.
Get Citation
About this article
Title

Iodine-131 for therapy of thyroid diseases. Physical and biological basis

Journal

Nuclear Medicine Review

Issue

Vol 15, No 2 (2012)

Pages

120-123

Published online

2012-08-28

Bibliographic record

Nucl. Med. Rev 2012;15(2):120-123.

Authors

Anna Wyszomirska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl